Holen Sie sich die Stockscreener-App
3.00
0.00%
0.00
Vorhandelsmarkt:
2.99
-0.010
-0.33%
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
Elicio Therapeutics Inc (ELTX) Cash Flow - TradingKey
Elicio Therapeutics Inc (ELTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elicio Therapeutics Inc (ELTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elicio Therapeutics Market Sentiment - Benzinga
ELTX|Elicio Therapeutics Inc|Price:3.000| - TradingKey
ELTX|Elicio Therapeutics Inc|Price:3.000|Chg%:-0.150 - TradingKey
TradingKey - TradingKey
Elicio Therapeutics, Inc. Revenue Breakdown – NASDAQ:ELTX - TradingView
Elicio Therapeutics Inc (ELTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 Elicio Therapeutics Inc For: 17 July By Investing.com - Investing.com Nigeria
Ladenburg Thalmann initiates coverage of Elicio Therapeutics (ELTX) with buy recommendation - MSN
Elicio Therapeutics (ELTX) awards 64,643 stock options to R&D and medical chief - Stock Titan
Elicio Therapeutics (ELTX) grants 52,832 stock options to Chief Scientific Officer - Stock Titan
Elicio Therapeutics (ELTX) awards 60,833 stock options to its CFO - Stock Titan
Elicio Therapeutics (ELTX) CEO awarded 186,944 stock options at 3.2000 - Stock Titan
ELTX Stock Price, Quote & Chart - ChartMill
Moti Investments discloses 6.1% stake in Elicio Therapeutics (NASDAQ: ELTX) - Stock Titan
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
Price-Driven Insight from (ELTX) for Rule-Based Strategy - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Shareholders to Connect - ACCESS Newswire
Enterprise value to revenue forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elicio Therapeutics, Inc. (ELTX) And Encourages Shareholders to Reach Out - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc.ELTX - PR Newswire
Why Is ELTX Stock Falling Today? - Stocktwits
[SCHEDULE 13G/A] Elicio Therapeutics, Inc. Amended Passive Investment Disclosure - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-08 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Shareholders to Learn More About the Investigation | NDAQ:ELTX | Press Release - Stockhouse
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ELICIO THERAPEUTICS ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING - Moomoo
Elicio Therapeutics closes $15 million stock offering - Investing.com India
Elicio Therapeutics Closes $15 Million Registered Direct Offering - marketscreener.com
Elicio Therapeutics closes $15 million stock offering By Investing.com - Investing.com South Africa
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirt - The National Law Review
Enterprise value to EBIT forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Elicio Therapeutics (ELTX) Stock Forum and Discussion - Moomoo
Price to sales forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Enterprise value to EBITDA forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Elicio Therapeutics stock tumbles on $15M offering - Investing.com
Elicio Therapeutics stock tumbles on $15M offering By Investing.com - Investing.com India
Form 424B5 Elicio Therapeutics Inc For: 2 July By Investing.com - Investing.com India
Form 424B5 Elicio Therapeutics, - StreetInsider
Elicio Therapeutics (ELTX) raises ~$15.0M via 4.38M-share placement - Stock Titan
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment - Yahoo Finance
Elicio Therapeutics raises $15M in registered direct offering By Investing.com - Investing.com Australia
Elicio Therapeutics Prices $15 Million Registered Direct Offering at $3.43; Signs Purchase, Placement Pacts - TradingView
Elicio Therapeutics (ELTX) prices $15M registered direct equity offering - Stock Titan
Elicio Therapeutics Prices $15 Million Direct Offering - marketscreener.com
Elicio Therapeutics prices $15M stock offering to fund cancer immunotherapy trials. - Pluang
Elicio locks in $15M to fund Phase 1 KRAS cancer trial - Stock Titan
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):